Lawson, N. | bioRxiv Science

bioRxiv2021

Heterogeneous pdgfrβ+ cells regulate coronary vessel development and revascularization during heart regeneration

Endothelial cells emerge from the atrioventricular canal (AVC) to form nascent coronary blood vessels in the juvenile zebrafish heart. We found that pdgfr{beta} is first expressed in the epicardium around the AVC and later becomes localized mainly in the mural cells. pdgfr{beta} mutant fish display severe defects in mural cell recruitment and coronary vessel development. pdgfr{beta}+ mural cells are heterogeneous and those associated with coronary arteries also express cxcl12b. Mural cells positive for both pdgfr{beta} and cxcl12b transgenic reporters had elevated expression of smooth muscle cell genes. Interestingly, these mural cells were associated with coronary arteries even in the absence of Pdgfr{beta}, although smooth muscle gene expression was downregulated in these cells. We found that pdgfr{beta} expression dynamically changes in the epicardium derived cells, which we found to be a heterogeneous population. mdka was identified as a gene upregulated in subpopulations of pdgfr{beta}+ cells during heart regeneration. However, pdgfr{beta} but not mdka mutants showed defects in heart regeneration. Our results demonstrated that pdgfr{beta}+ cells and Pdgfr{beta} signaling are essential for coronary development and heart regeneration. SUMMARY STATEMENTHeterogeneous pdgfr{beta} positive cells are present in developing and regenerating zebrafish hearts and are required for development of mural cells and their association with the nascent coronary vessels during zebrafish heart development and regeneration.

developmental biology↗

bioRxiv2020

VEGFC induced cell cycle arrest mediates sprouting and differentiation of venous and lymphatic endothelial cells

The emergence and growth of new vessels requires a tight synchronization between proliferation, differentiation and sprouting, traditionally thought to be controlled by mitogenic signals, especially of the VEGF family. However, how these cues are differentially transduced, by sometimes even neighboring endothelial cells (ECs), remains unclear. Here we identify cell-cycle progression as a new regulator of EC sprouting and differentiation. Using transgenic zebrafish illuminating cell-cycle stages, we show that venous and lymphatic precursors sprout from the Cardinal Vein (CV) exclusively in G0/G1, and reveal that cell-cycle arrest is induced in these ECs by p53 and the CDK-inhibitors p27 and p21. Moreover, we demonstrate that in vivo, chemical and genetic cell-cycle inhibition, results in massive vascular growth. Mechanistically, we identify the mitogenic VEGFC/VEGFR3/ERK axis as direct inducer of cell-cycle arrest in angiogenic ECs and characterize the cascade of events governing venous vs. lymphatic segregation and sprouting. Overall, our results uncover an unexpected mechanism whereby mitogen-controlled cell-cycle arrest boosts sprouting, raising important questions about the use of cell-cycle inhibitors in pathological angiogenesis and lymphangiogenesis.

developmental biology↗